Caspase-6 cleaves tau at D402-T403 and produces a Tau 1–402 fragment which has been used as biomarker for AD in CSF (Ramcharitar et al., 2013; LeBlanc et al., 2014; Quinn et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.